Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 12 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

2 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(66.7%)
Phase 4
2(33.3%)
6Total
N/A(4)
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (12)

Showing 12 of 12 trials
NCT06877052Completed

Prediction of Venous Thrombosis After Fracture Operation: Comparative Analysis of Different Fracture Sites

Role: lead

NCT06877039Completed

Characteristics of Clinical Laboratory Indicators in Patients with Dengue Fever

Role: lead

NCT05020210Unknown

Effect of Early Treatment With Sivelestat Sodium in ARDS Patients

Role: collaborator

NCT04990752Unknown

Effects of Ulinastatin on Inflammatory Response During ECMO Support

Role: collaborator

NCT03257826Not ApplicableUnknown

The Effect of Percutaneous Kirschner Wire Technique in Management of CPT Under One Year Old

Role: collaborator

NCT02640040Not ApplicableUnknown

The Effect of Combined Surgery in Management of Congenital Pseudarthrosis of Tibia

Role: collaborator

NCT02896114Unknown

A Retrospective Study of Surgical Treatment of Congenital Pseudarthrosis of Tibia in China

Role: collaborator

NCT03346226Phase 4Unknown

How Different Sedatives Affect Hip Fracture Patient's Postoperative Delirium

Role: collaborator

NCT02723825Not ApplicableNot Yet Recruiting

Study of Prognostic Factors of the Distal Epiphysis of the Tibia Fracture Prognosis

Role: lead

NCT02163603Unknown

A Trial on the Opportunity and Treatment of Residual Deformity After Reduction in Developmental Dislocation of the Hip

Role: collaborator

NCT02633904Not ApplicableUnknown

Investigation of the Femoral Shortening Osteotomy in the Developmental Dislocation of the Hip (FSODDH)

Role: collaborator

NCT00548223Phase 4Completed

The Secondary Prevention Trial for Ischemic Stroke With DengzhanShengmai Capsule

Role: collaborator

All 12 trials loaded